Cargando…

Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae

BACKGROUND: Follow-up after hospital discharge of SARS-CoV-2 survivors represents a huge burden on the healthcare system. We attempt to assess the utility of symptoms and health-related quality of life questionnaire (SF-12) to identify SARS CoV2 pulmonary sequelae. METHODS: Prospective, non-interven...

Descripción completa

Detalles Bibliográficos
Autores principales: Vannini, Luca, Laynez-Carnicero, Ana, Bobis-Alvarez, Carlos, Figueroa-Mora, Angelica, Poncela-Mireles, Javier, Hernandez, Francisca Gonzalvo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526003/
https://www.ncbi.nlm.nih.gov/pubmed/36213211
http://dx.doi.org/10.1016/j.medcle.2022.02.027
_version_ 1784800783144845312
author Vannini, Luca
Laynez-Carnicero, Ana
Bobis-Alvarez, Carlos
Figueroa-Mora, Angelica
Poncela-Mireles, Javier
Hernandez, Francisca Gonzalvo
author_facet Vannini, Luca
Laynez-Carnicero, Ana
Bobis-Alvarez, Carlos
Figueroa-Mora, Angelica
Poncela-Mireles, Javier
Hernandez, Francisca Gonzalvo
author_sort Vannini, Luca
collection PubMed
description BACKGROUND: Follow-up after hospital discharge of SARS-CoV-2 survivors represents a huge burden on the healthcare system. We attempt to assess the utility of symptoms and health-related quality of life questionnaire (SF-12) to identify SARS CoV2 pulmonary sequelae. METHODS: Prospective, non-interventional follow-up study. A cardiopulmonary exercise test, functional respiratory test (PFT), SF12 questionnaire were performed after hospitalization at six months after the first positive PCR smear. RESULTS: 41 patients were included, female (39%), mean age 57.3 ± 13.7 years. 70% persisted with symptoms. 46% presented a maximum oxygen consumption below 80% of predicted. SF-12 physical domain score was significantly reduced in patients with altered PFT (32.7 vs. 45.9; p < 0.001) and obtained the best sensitivity and specificity to identify PFT alterations (AUC 0.862, Sensitivity 85.7%, Specificity 81.5%). CONCLUSIONS: SF-12 questionnaire shows high sensitivity and specificity to detect SARS CoV2 survivors with pulmonary function alterations.
format Online
Article
Text
id pubmed-9526003
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-95260032022-10-03 Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae Vannini, Luca Laynez-Carnicero, Ana Bobis-Alvarez, Carlos Figueroa-Mora, Angelica Poncela-Mireles, Javier Hernandez, Francisca Gonzalvo Med Clin (Engl Ed) Brief Report BACKGROUND: Follow-up after hospital discharge of SARS-CoV-2 survivors represents a huge burden on the healthcare system. We attempt to assess the utility of symptoms and health-related quality of life questionnaire (SF-12) to identify SARS CoV2 pulmonary sequelae. METHODS: Prospective, non-interventional follow-up study. A cardiopulmonary exercise test, functional respiratory test (PFT), SF12 questionnaire were performed after hospitalization at six months after the first positive PCR smear. RESULTS: 41 patients were included, female (39%), mean age 57.3 ± 13.7 years. 70% persisted with symptoms. 46% presented a maximum oxygen consumption below 80% of predicted. SF-12 physical domain score was significantly reduced in patients with altered PFT (32.7 vs. 45.9; p < 0.001) and obtained the best sensitivity and specificity to identify PFT alterations (AUC 0.862, Sensitivity 85.7%, Specificity 81.5%). CONCLUSIONS: SF-12 questionnaire shows high sensitivity and specificity to detect SARS CoV2 survivors with pulmonary function alterations. Elsevier España, S.L.U. 2022-10-07 2022-10-01 /pmc/articles/PMC9526003/ /pubmed/36213211 http://dx.doi.org/10.1016/j.medcle.2022.02.027 Text en © 2022 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Report
Vannini, Luca
Laynez-Carnicero, Ana
Bobis-Alvarez, Carlos
Figueroa-Mora, Angelica
Poncela-Mireles, Javier
Hernandez, Francisca Gonzalvo
Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae
title Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae
title_full Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae
title_fullStr Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae
title_full_unstemmed Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae
title_short Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae
title_sort accuracy of quality of life questionnaire as a diagnostic tool for sars-cov-2 pulmonary sequelae
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526003/
https://www.ncbi.nlm.nih.gov/pubmed/36213211
http://dx.doi.org/10.1016/j.medcle.2022.02.027
work_keys_str_mv AT vanniniluca accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae
AT laynezcarniceroana accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae
AT bobisalvarezcarlos accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae
AT figueroamoraangelica accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae
AT poncelamirelesjavier accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae
AT hernandezfranciscagonzalvo accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae